Shares in Hikma Pharmaceuticals fell after the company cut core operating profit guidance for the year and lowered its midterm outlook. Shares in early European trade were down 220 pence, or 12%, at 1 ...

CFAO Healthcare South Africa proudly announces that it has attained a Level 3 Broad-Based Black Economic Empowerment (B-BBEE) ...

KUWAIT CITY, Nov 6: Developing an advanced local pharmaceutical industry is a cornerstone of Kuwait’s healthcare “flexibility ...

Expanding Access to Lyophilized Therapies: Reunite removes reliance on vial kits and manual reconstitution, making ...

Investing in pharmaceutical companies with robust product pipelines and diversified revenue streams is often considered a ...

Drug major Sun Pharma on Wednesday said it is open to enhancing its manufacturing footprint in the US amid the Trump ...

Some eight months into the launch of Onapgo, the Parkinson’s disease infusion pump Supernus Pharmaceuticals spent years fighting to get across the FDA finish line, the drugmaker is discovering that ...

The Trump administration is negotiating an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some ...

Richard Ascroft, the company's chief executive officer for the North America business, stated that the Mumbai-based drug ...

Discover key Royalty Pharma Q3 2025 earnings insights—double-digit growth, new acquisitions, and raised guidance for investors.

Sun Pharma is considering expanding its manufacturing in the U.S. due to new tariffs on medicines. CEO Richard Ascroft ...